OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

Charity registration number 1078956

Company registration number 03640937 (England and Wales)

CHAI-LIFELINE CANCER CARE

(A COMPANY LIMITED BY GUARANTEE)

ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) LEGAL AND ADMINISTRATIVE INFORMATION

Trustees S. Zuckerbrod L. Hager A. Tookman R. Segal A. Maurice P. Hertz L. Shelley R. Saville (Appointed 18 August 2023) Charity number 1078956 Company number 03640937 Registered office 325-327 Oldfield Lane North Greenford Middlesex UB6 0FX Auditor Landau Morley LLP 325-327 Oldfield Lane North Greenford Middlesex UB6 0FX

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) CONTENTS

Page
Trustees' report 1 - 8
Independent auditor's report 9 - 11
Statement of financial activities 12
Balance sheet 13
Statement of cash flows 14
Notes to the financial statements 15 - 28

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) FOR THE YEAR ENDED 31 MARCH 2023

The Trustees (who are also directors for the purpose of the Companies Act) present their annual report together with the audited financial statements of Chai-Lifeline Cancer Care (the company) for the year ended 31 March 2023.

The Trustees confirm that the Annual report and financial statements of the company comply with the current statutory requirements, have been prepared in accordance with the accounting policies set out in the notes to the financial statements and comply with the charity's governing document, the Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)".

Since the company qualifies as small under section 383, the strategic report required of medium and large companies under The Companies Act 2006 (Strategic Report and Director’s Report) Regulations 2013 is not required.

Reference and Administrative Details

Reference and administrative details are shown in the schedule of members of the board and professional advisors on the legal and administrative information page of the financial statements.

Structure, Governance and Management

Chai-Lifeline Cancer Care is a company limited by guarantee governed by its Memorandum and Articles of Association dated 24[th] September 1998 as amended by written resolution on 7[th] August 2012. It has no share capital. It is a registered charity, Charity number 1078956. The charity is governed by the Companies Act 2006 and the Charities Act 2011.

Appointment of Trustees, Induction and Training

Trustees may be recruited from the Jewish Community. They will be able to demonstrate an ability to support, promote and lead development of the charity. They will have an area of expertise that will enhance the work of the Trustees and contribute to the achievement of the charity’s objectives.

New Trustees undergo induction training to brief them on their legal obligations under charity and company law, the content of the Memorandum and Articles of Association, the committee and decision-making processes, the objectives and financial performance of the charity. Trustees are encouraged to attend appropriate external training events where these will facilitate the undertaking of their role.

Organisation

The Board of Trustees administers and determines the general policy of the charity.

The Chief Executive, Lisa Steele, is appointed by the Trustees to manage the day-to-day operations of the charity with delegated responsibility.

The vast majority of Chai’s staff provides face to face services for clients.

Related Parties

In the year ended 31[st] March 2023, the charity did not undertake any transactions with related parties other than those disclosed in the financial statements.

Risk Management

The Trustees assess the major risks to which the charity is exposed and implement systems to mitigate both financial and non-financial risks.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

Chai has a risk register which is reviewed regularly. The Trustees also ensure that clinical governance is in place, throughout all service areas of therapy, complementary therapy and counselling, and physical and psychological groups.

Chai operates a high level of confidentiality with respect to all client information.

Achievable fundraising targets are set to cover realistic budgets, which are monitored on a monthly basis together with cash forecasts.

Objectives and Activities

The objectives of the charity are:

To promote the relief of persons suffering from cancer and their families within the Jewish Community and to prevent sickness by promoting good health care and the provision of education and screening programmes for persons within the Jewish community, whether suffering from cancer or not.

The charity has the general aim of providing an extensive range of services including counselling, therapies, complementary therapies, advocacy, legal, financial and spiritual advice, group activities and support groups for the Jewish community.

Chairman’s statement

The demand for Chai’s expertise and care continues unabated. More people are being diagnosed with cancer and significant advances in surgery and treatment mean that thankfully more people are living for longer, albeit with physical and emotional changes which affect both the cancer patients and their family members. Therefore, the call on Chai’s services is relentless and our clients often refer to us as the constant factor during a time of great uncertainty in their lives.

In addition, Chai is still seeing the impact of Covid-19 on our clients, who experienced delays in screening, diagnosis and treatment due to the pandemic.

Chai does not receive any statutory funding but was able to continue to provide specialised services mainly through a matched funding campaign which also afforded the opportunity to inform the community of the comprehensive range of support services which Chai provides.

What Chai provides

Chai provides services to the Jewish community and these can be accessed either by self-referral or referral from a professional.

Chai’s reputation for providing a highly professional service combined with sensitivity and care has encouraged those needing our service to contact us. Services are provided from our flagship centre in Hendon and from our 11 satellite centres across the UK. For those unable to access a Chai site, support will be provided through telephone counselling, Skype and Zoom, nationally and internationally. Awareness of our services has built significantly with enquiries from Israel, USA, Canada, Australia, Europe and South Africa.

Chai services provided to clients are:

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

Many of the support groups are online to allow our clients to join nationally. This has proved particularly beneficial for clients not within geographical reach of a Chai centre.

Objectives for 2022/2023

All objectives were achieved.

Major areas of Fundraising activity

Performance and achievements in 2022/2023

To meet our clients’ many and diverse needs, Chai now provides 67 specialised support services across the nationwide network of 11 satellite centres. For those who are not able to come to us, services can be provided in clients’ own homes, hospitals and hospices through our Home Support Services. In addition, clients can still access our expertise and care, including some groups, through Zoom.

The feedback from our clients, both the cancer patients and their family members, is that our services make a tangible difference and that this ongoing support brings considerable relief and comfort. Without it their lives would be of poorer quality, as there is nowhere else for them to receive this level of specialised support.

Due to the increase in the number of parents being diagnosed, many of whom have children, we have needed to expand our team of specialised children and teenage therapists to meet the demand. In addition we have further developed our ‘Chai in Schools’ programme which supports these children and provides practical advice and guidance to teachers.

Chai together with Jnetics began working together with the NHS to raise awareness of the NHS Jewish BRCA Testing programme, with a soft launch starting at the end of January.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

Service Activity

Number of New Clients:

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

Developing Services

Chai’s Medical Advisory Panel ensures that Chai is kept updated on all developments of cancer treatment and care. This knowledge, together with our clients’ feedback, enables us to refine and plan the range of services that are needed to meet the complex and evolving needs of our clients.

Chai and Jenetics have been officially appointed by NHS England to lead a community-wide engagement campaign supporting the new NGS Jewish BRCA Testing Programme. The campaign will educate and inform the community about the ground breaking BRCA testing programme.

Research has shown that people in the Jewish population are six times more likely to carry a mutated gene fault. Chai’s specialised counsellors receive additional training from the Royal Marsden and Northwick Hospital genetics teams to support all those who wish to discuss the implications of being tested and for those who have been tested positive with a mutated gene.

Chai’s expert support is being called upon increasingly from primary and secondary schools across the UK through our ‘Chai in Schools’ service. We are continuing to recruit for our team of specialised children’s therapists to meet this demand.

Managing the long-term physical and emotional impact of living with a cancer diagnosis is an on-going challenge for our clients. However, with counsellors providing expert support and with the breadth of our complementary and therapeutic treatments, Chai makes a significant difference to people’s lives.

Fundraising

A matched funding campaign in November was successful in both raising funds and awareness.

Chai’s two annual appeals, Pesach and Rosh Hashana were both successful.

We were able to hold the annual Club 18 Golf Day, Ladies Lunch and Rosh Hashana Gift Sale.

Quality assurance

A specialist independent consultant has reviewed all Chai’s policies and all members of staff have attended GDPR awareness and training sessions across the UK Chai centres.

Chai continues to use the quality assurance scheme to assist it in monitoring the quality of its services and to contribute to the future development of new services. The system is an accredited tool which is used nationally in cancer support organisations. The system is called MYCaW (Measure Yourself Concerns and Wellbeing) and is used for most clients who use Chai’s services.

The Counsellors’ Handbook and Complementary Therapists’ handbook have both been reviewed and are used across all of our sites to clarify processes and to ensure consistency throughout the organisation.

Chai’s Staff Handbook has again been updated in line with current legislation.

The Volunteers’ Handbook has been reviewed and constantly updated.

All further policies are reviewed and constantly updated.

Training for therapists and counsellors, including continued professional development, is provided.

Two external Counselling Supervisors support the Psychological Teams nationally.

The annual Natalie Shipman Memorial Lecture took place in October 2022. Professor Jonathan Ledermann, Professor of medical Oncology and the Clinical Director at UCL Cancer Institute, spoke about ‘How BRCA gene mutations are spearheading ovarian cancer treatment’.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

Objectives for 2023/2024

Financial review

Donations received from all sources amounted to £4,334,865 (2021/22: £3,645,622) representing a 18.91% increase from last year.

Funds were raised from specific major fundraising and community events, appeals, private donations, legacies, patronage campaign and commemorative giving.

Chai also received unsolicited donations.

During the year Chai expended:

Cost of providing services - £2,750,606 (2021/22: £2,536,032)

Fundraising and publicity costs - £612,610 (2021/22: £473,493)

Governance costs - £23,393 (2021/22: £18,306)

Annual accounts are delivered to the Charity Commission within 10 months of the financial year-end.

Financial Health

At 31[st] March 2023 there was a net surplus of income for the year of £789,987 (2021/22: £665,237).

Disclosure of Trustee remuneration

See note 10 to the accounts.

Investments

See note 14 to the accounts.

The charity’s wholly owned subsidiary Chai-Lifeline Services Ltd remains dormant. At 31st March 2023 the company’s reserves totalled £2.

The Trustees have adopted a low-risk strategy to the investment of the charity’s funds. The aim of the investment activity is to obtain a reasonable balance between capital growth and income so the charity can meet future demands as well as current needs.

The charity’s investment holdings are currently managed by three independent investment managers, with whom cautious investment mandates have been agreed. The investment managers report on performance and compliance with their mandates on a regular basis. The Trustees regularly monitor the levels of investments and the returns received to generate sufficient financial return to enable the charity to achieve its Objectives effectively and without interruption.

The charity’s investment holdings are diversified by additional holdings in current and short-term cash deposits.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

Volunteers

Chai currently has 120 volunteers who work on behalf of the charity in a variety of roles including befriending, transport, reception duties and administration. The average volunteer spends 2-3 hours a week assisting Chai. All volunteers receive initial training and ongoing supervision.

Reserves Policy

The trustees are committed to meeting the expectations of all clients turning to Chai for support and continue to explore unmet need. No client is turned away and no statutory funding is received.

Our charity supports very sick people and those who are close to them. Our activities include offering educational resources for patients, carers and professionals and our future plans are to proactively explore innovative methods of health promotion with our clientele. In view of the nature of the illness we frequently have a long term commitment with our patients and their families. The Trustees therefore think the charity's reserves policy should reflect this long term engagement and Chai is aiming to build sufficient unrestricted free funds to cover at least two years’ future operational costs, for the sake of prudence.

The Trustees have allocated £1m towards an upcoming building project at the Flagship Centre in NW London.

At 31 March 2023 free reserves are £2,997,703. The management team continue to put a strong emphasis on building these reserves and have a programme of financial planning to accumulate and sustain these reserves, which will need to increase in line with the finances required to fund the growing number of clients using the services for increasing periods of time.

Trustees

The Trustees, who are also the directors for the purpose of company law, and who served during the year and up to the date of signature of the financial statements were:

S. Zuckerbrod

L. Hager

J. Hodes

A. Tookman

R. Segal

A. Maurice

P. Hertz L. Shelley Lord Young of Graffham

R. Saville

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

Statement of Trustees' responsibilities

The Trustees, who are also the directors of Chai-Lifeline Cancer Care for the purpose of company law, are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company Law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that year.

In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Disclosure of information to auditor

Each of the Trustees has confirmed that there is no information of which they are aware which is relevant to the audit, but of which the auditor is unaware. They have further confirmed that they have taken appropriate steps to identify such relevant information and to establish that the auditor is aware of such information.

This report was approved by the Trustees on 21 December 2023 and signed on their behalf by:

L. Hager Trustee

R. Segal Trustee

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT TO THE TRUSTEES OF CHAI-LIFELINE CANCER CARE

Opinion

We have audited the financial statements of Chai-Lifeline Cancer Care (the ‘charity’) for the year ended 31 March 2023 which comprise the statement of financial activities, the balance sheet, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the Trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The Trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 require us to report to you if, in our opinion:

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF CHAI-LIFELINE CANCER CARE

Responsibilities of Trustees

As explained more fully in the statement of Trustees' responsibilities, the Trustees, who are also the directors of the charity for the purpose of company law, are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the Trustees are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

Owing to the inherent limitations of an audit, there is an unavoidable risk that some material misstatements of the financial statements may not be detected, even though the audit is properly planned and performed in accordance with the ISAs (UK).

The potential effects of inherent limitations are particularly significant in the case of misstatement resulting from fraud because fraud may involve sophisticated and carefully organized schemes designed to conceal it, including deliberate failure to record transactions, collusion or intentional misrepresentations being made to us.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF CHAI-LIFELINE CANCER CARE

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https:// www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the charity’s trustees, as a body, in accordance with part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charity's trustees those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Landau Morley LLP Chartered Accountants Statutory Auditor

21 December 2023

325-327 Oldfield Lane North Greenford Middlesex UB6 0FX

Landau Morley LLP is eligible for appointment as auditor of the charity by virtue of its eligibility for appointment as auditor of a company under section 1212 of the Companies Act 2006.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 MARCH 2023

Unrestricted
funds
2023
Notes
£
Income and endowments from:
Donations and
legacies
3
4,319,865
Investments
4
69,876
Other income
5
-
Total income
4,389,741
Expenditure on:
Raising funds
6
612,610
Charitable activities
7
2,666,801
Total expenditure
3,279,411
Net gains/(losses) on
investments
11
(251,538)
Net incoming/(outgoing)
resources before
transfers
858,792
Gross transfers
between funds
3,207,067
Net movement in funds
4,065,859
Fund balances at 1 April
2022
8,490,117
Fund balances at 31
March 2023
12,555,976		 Restricted
funds
2023
£
15,000
-
-
15,000
-
83,805
83,805
-
(68,805)
(3,207,067)
(3,275,872)
3,275,872
-		 Total
Unrestricted
funds
2023
2022
£
£
4,334,865
3,642,622
69,876
21,406
-
6,411
4,404,741
3,670,439
612,610
473,493
2,750,606
2,370,149
3,363,216
2,843,642
(251,538)
1,323
789,987
828,120
-
8,112
789,987
836,232
11,765,989
7,653,885
12,555,976
8,490,117		 Restricted
funds
2022
£
3,000
-
-
3,000
-
165,883
165,883
-
(162,883)
(8,112)
(170,995)
3,446,867
3,275,872		 Total
2022
£
3,645,622
21,406
6,411
Donations and
legacies
3
Investments
4
Other income
5
Total income
Expenditure on:
Raising funds
6
Charitable activities
7
Total expenditure
Net gains/(losses) on
investments
11
Net incoming/(outgoing)
resources before
transfers
Gross transfers
between funds
Net movement in funds
Fund balances at 1 April
2022
Fund balances at 31
March 2023
3,673,439
473,493
2,536,032
3,009,525
1,323
665,237
-
665,237
11,100,752
11,765,989

The statement of financial activities includes all gains and losses recognised in the year.

All income and expenditure derive from continuing activities.

The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) BALANCE SHEET

AS AT 31 MARCH 2023

Notes
Fixed assets
Tangible assets
13
Investments
14
Current assets
Debtors
16
Investments
17
Cash at bank and in hand
Creditors: amounts falling due within
one year
18
Net current assets
Total assets less current liabilities
Income funds
Restricted funds
19
Unrestricted funds
Designated funds
20
General unrestricted funds		 2023
£
£
4,677,793
4,880,480
9,558,273
296,291
674,202
2,351,756
3,322,249
(324,546)
2,997,703
12,555,976
-
1,000,000
11,555,976
12,555,976
12,555,976		 2022
£
£
4,761,606
4,612,428
9,374,034
288,640
172,467
2,201,864
2,662,971
(271,016)
2,391,955
11,765,989
3,275,872
-
8,490,117
8,490,117
11,765,989		 2022
£
£
4,761,606
4,612,428
9,374,034
288,640
172,467
2,201,864
2,662,971
(271,016)
2,391,955
11,765,989
3,275,872
-
8,490,117
8,490,117
11,765,989
9,374,034
2,391,955
11,765,989
3,275,872
8,490,117
11,765,989

The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 March 2023, although an audit has been carried out under section 144 of the Charities Act 2011.

The directors acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements under the requirements of the Companies Act 2006, for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Trustees on 21 December 2023

L. Hager R. Segal Trustee Trustee

Company Registration No. 03640937

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 MARCH 2023

2023 2022
Notes £ £ £ £
Cash flows from operating activities
Cash generated from operations 25 1,179,703 978,093
Investing activities
Purchase of tangible fixed assets (78,361) (29,104)
Purchase of investments (1,019,589) (4,246,585)
Proceeds from disposal of investments (1,737) 357,524
Investment income received 69,876 21,406
Net cash used in investing activities (1,029,811) (3,896,759)
Net cash used in financing activities - -
Net increase/(decrease) in cash and cash
equivalents 149,892 (2,918,666)
Cash and cash equivalents at beginning of year 2,201,864 5,120,530
Cash and cash equivalents at end of year 2,351,756 2,201,864

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

1 Accounting policies

Charity information

Chai-Lifeline Cancer Care is a private company limited by guarantee incorporated in England and Wales. The registered office is 325-327 Oldfield Lane North, Greenford, Middlesex, UB6 0FX.

1.1 Accounting convention

The financial statements have been prepared in accordance with the charity's governing document, the Companies Act 2006 and “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)” (as amended for accounting periods commencing from 1 January 2019).

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the Trustees have a reasonable expectation that the Charity has adequate resources to support the current level of expenditure and to continue in operational existence for the foreseeable future.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the Trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4 Income

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

1 Accounting policies

(Continued)

1.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Fundraising costs are those incurred in seeking voluntary contributions and do not include the costs of disseminating information in support of the charitable activities. Support costs are those costs incurred directly in support of expenditure on the objects of the company and include project management carried out at Headquarters. Governance costs are those incurred in connection with administration of the company and compliance with constitutional and statutory requirements.

Costs of generating funds are costs incurred in attracting voluntary income, and those incurred in trading activities that raise funds.

Charitable activities and Governance costs are costs incurred on the company's educational operations, including support costs and costs relating to the governance of the company apportioned to charitable activities.

1.6 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold property 2% straight line Office equipment 15% straight line Fixtures and fittings 15% straight line Computer equipment 33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.7 Fixed asset investments

Fixed asset investments are initially measured at transaction price excluding transaction costs, and are subsequently measured at fair value at each reporting date. Changes in fair value are recognised in net income/(expenditure) for the year. Transaction costs are expensed as incurred.

A subsidiary is an entity controlled by the charity. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.8 Impairment of fixed assets

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

1 Accounting policies

(Continued)

1.9 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.10 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.11 Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.12 Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2023

3 Donations and legacies

Unrestricted
Restricted
funds
funds
2023
2023
£
£
General donations
372,684
-
Patronage
54,375
-
Legacies
701,483
-
New Year appeal
175,707
-
Pesach appeal
85,504
-
Golf days
43,685
-
Income from Dinner
Function
9,782
-
Chai Challenge
79,740
-
Ladies Events
103,335
-
London Marathon
39,882
-
Manchester events
10,991
-
Other fundraising events
213,624
-
Service donations
186,386
15,000
Annual Campaigns
2,242,687
-
4,319,865
15,000		 Total
Unrestricted
funds
2023
2022
£
£
372,684
355,712
54,375
60,688
701,483
138,544
175,707
186,034
85,504
79,374
43,685
113,494
9,782
7,631
79,740
-
103,335
-
39,882
18,709
10,991
6,465
213,624
86,257
201,386
199,860
2,242,687
2,389,854
4,334,865
3,642,622		 Restricted
funds
2022
£
-
-
-
-
-
-
-
-
-
-
-
-
3,000
-
3,000		 Total
2022
£
355,712
60,688
138,544
186,034
79,374
113,494
7,631
-
-
18,709
6,465
86,257
202,860
2,389,854
3,645,622

4 Investments

**Unrestricted ** Unrestricted
funds funds
2023 2022
£ £
Investment income 61,633 19,965
Interest receivable 8,243 1,441
69,876 21,406
Other income
Total Unrestricted
funds
2023 2022
£ £
Grants - 6,411

5 Other income

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

6 Raising funds

Unrestricted
funds
2023
£
Fundraising and publicity
Fundraising costs
263,220
Staff costs
318,981
Fundraising and publicity
582,201
Investment management
30,409
612,610
Costs of Raising funds comprised:
2023
Fundraising and publicity
General donations
31,712
Patronage
6,987
Legacy costs
3,280
New Year appeal
34,813
Pesach appeal
22,252
Golf days
11,918
Dinner Function
832
Chai Challenge
6,786
Ladies Events
56,213
London Marathon
7,056
Manchester events
28,470
Other fundraising events
43,588
Services
17,136
Annual Campaigns
311,158
Total
582,201		 Total
2022
£
185,701
270,127
455,828
17,665
473,493
2022
27,398
5,864
4,700
33,900
18,519
25,696
588
-
4,049
23,658
22,969
15,625
272,862
455,828

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2023

7 Charitable activities

Staff costs
Freelance therapists' and consultants' costs
Publications costs
Advertising services
Training supervisor costs
Room hire costs
Patients' aids/Consumables
Laundry services
Other costs
Share of support costs (see note 8)
Share of governance costs (see note 8)
Analysis by fund
Unrestricted funds
Restricted funds		 2023
£
776,448
808,494
155,788
88,354
44,458
62,827
14,274
10,086
87,046
2,047,775
679,438
23,393
2,750,606
2,666,801
83,805
2,750,606		 2022
£
686,053
782,813
124,197
93,641
41,851
55,749
19,863
11,032
59,813
1,875,012
642,714
18,306
2,536,032
2,370,149
165,883
2,536,032

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2023

8 Support costs

Support costs
Staff costs
Depreciation
Premises costs
Rates, water and
electricity
Newspapers and journals
Computer and internet
expenses
Telephone
Other costs
Postage and printing
Legal & Professional fees
Audit fees
Accountancy
Analysed between
Charitable activities		 Support
costs
Governance
costs
£
£
182,633
-
162,175
-
110,921
-
47,474
-
6,788
-
47,336
-
11,655
-
43,180
-
24,105
-
43,171
-
-
12,164
-
11,229
679,438
23,393
679,438
23,393		 2023Support costs Governance
costs
£
£
£
182,633
154,368
-
162,175
164,439
-
110,921
116,214
-
47,474
37,124
-
6,788
6,891
-
47,336
42,399
-
11,655
10,099
-
43,180
34,279
-
24,105
28,145
-
43,171
48,756
-
12,164
-
9,516
11,229
-
8,790
702,831
642,714
18,306
702,831
642,714
18,306		 2022
£
154,368
164,439
116,214
37,124
6,891
42,399
10,099
34,279
28,145
48,756
9,516
8,790
661,020
661,020

In respect of the year ended 31 March 2023, of the total depreciation cost of £162,175 (2022: £164,439), £111,490 (2022: £119,139) is attributable to unrestricted funds and £50,685 (2022: £45,300) is attributable to restricted funds.

In respect of the year ended 31 March 2023, of the total premises costs of £110,921 (2022: £116,214), £92,800 (2022: £93,826) is attributable to unrestricted funds and £18,121 (2022: £22,388) is attributable to restricted funds.

Governance costs include payments to the auditors of £12,164 (2022: £9,516) for audit fees and £11,229 (2022: £8,790) for non audit fees.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

9 Employees

Number of employees

The average monthly number of employees during the year was:

Employment costs
Wages and salaries
Social security costs
Other pension costs		 2023
Number
29
2023
£
1,109,763
107,954
60,345
1,278,062		 2022
Number
27
2022
£
961,111
96,668
52,769
1,110,548

The key management personnel of the charity comprise one of the Trustees and the Chief Executive. The total employee benefits of the key management personnel of the Charity were £228,775 (2022: £230,604).

Of the employees whose emoluments exceed £60,000, 3 (2022: 2) have retirement benefits accruing under defined contribution pension schemes.

The number of employees whose annual remuneration was £60,000 or more were:

2023 2022
Number Number
In the band £60,001 - £70,000 1 -
In the band £90,001 - £100,000 1 1
In the band £110,001 - £120,000 1 1

10 Trustees' remuneration

The Charity Commission approved payments of remuneration, benefits in kind and pension contributions to Louise Hager, a trustee of the Charity, in her role as Chairman. Louise Hager promotes the charity nationally and internationally and leads the fundraising department. Payments are made pursuant to the authority set out in Article 5 of the Charity's Articles of Association.

Remuneration paid to the trustee (including benefits in kind and pension contributions) during the year ended 31 March 2023 totalled £127,720 (2022: £123,019).

During the year retirement benefits were accruing to 1 Trustee (2022: 1) in respect of defined contribution pension schemes.

No other Trustee received any remuneration or reimbursed expenses in the year.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2023

11 Net gains/(losses) on investments

Unrestricted Unrestricted Unrestricted Unrestricted
funds funds
2023 2022
£ £
Revaluation of investments (251,538) 1,323

12 Taxation

The charity is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects.

13 Tangible fixed assets

Cost
At 1 April 2022
Additions
At 31 March 2023
Depreciation and impairment
At 1 April 2022
Depreciation charged in the year
At 31 March 2023
Carrying amount
At 31 March 2023
At 31 March 2022		 Freehold
property
£
6,198,508
6,540
6,205,048
1,528,132
102,501
1,630,633
4,574,415
4,670,376		 Office
equipment
Fixtures and
fittings
£
£
81,604
724,202
915
38,998
82,519
763,200
79,300
646,373
908
40,431
80,208
686,804
2,311
76,396
2,304
77,829		 Computer
equipment
£
236,711
31,908
268,619
225,613
18,335
243,948
24,671
11,097		 Total
£
7,241,025
78,361
7,319,386
2,479,418
162,175
2,641,593
4,677,793
4,761,606

Included in freehold property is land with a historic cost of £1,080,000 (2022: £1,080,000) that is not depreciated.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2023

14 Fixed asset investments

Listed
investments
Other
investments
£
Cost or valuation
At 1 April 2022
4,612,426
2
Additions
1,019,589
-
Valuation changes
(251,537)
-
Transfer to current asset investments
(500,000)
-
At 31 March 2023
4,880,478
2
Carrying amount
At 31 March 2023
4,880,478
2
At 31 March 2022
4,612,426
2
2023
Other investments comprise:
Notes
£
Investments in subsidiaries
24
2
15
Financial instruments
2023
£
Carrying amount of financial assets
Instruments measured at fair value through profit or loss
674,202
16
Debtors
2023
Amounts falling due within one year:
£
Income tax recoverable and other debtors
210,261
Prepayments and accrued income
86,030
296,291		 Total
£
4,612,428
1,019,589
(251,537)
(500,000)
4,880,480
4,880,480
4,612,428
2022
£
2
2022
£
172,467
2022
£
215,732
72,908
288,640

Prepayments and accrued income include accrued income totalling £nil (2022: £23,996) in respect of amounts received in April 2023.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2023

17 Current asset investments

Unlisted investments

2023 2022
£ £
674,202 172,467

Current asset investments comprise fixed term deposits of £174,202 (2022: £172,467) held in the UK and overseas bonds of £500,000 (2022: £nil) in Israel.

18 Creditors: amounts falling due within one year

Creditors: amounts falling due within one year
Other taxation and social security
Trade creditors
Amounts owed to subsidiary undertakings
Accruals and deferred income		 2023
£
29,680
186,739
2
108,125
324,546		 2022
£
26,855
154,301
2
89,858
271,016

Accruals and deferred income include deferred income totalling £64,189 (2022: £58,094) in respect of amounts received in advance.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2023

19 Restricted funds

The income funds of the charity include restricted funds held on trust for specific purposes. These restricted funds comprise the following balances representing tangible assets which were created through donations and grants:

:

Balance at
1 April 2021
£
Chai Centre Building Fund
1,814,596
Chai Centre Extension Building Fund
1,466,051
Chai Centre - Outpatient Rehabilitation &
Palliative Care Service
95,195
Chai Centre - Manchester
71,025
3,446,867		 Movement in funds
Incoming
resources
Resources
expended
Transfers
Balance at
1 April 2022
£
£
£
£
-
(47,481)
(6,000)
1,761,115
-
(20,207)
-
1,445,844
3,000
(98,195)
-
-
-
-
(2,112)
68,913
3,000
(165,883)
(8,112)
3,275,872		 Movement in funds
Incoming
resources
Resources
expended
Transfers
31
£
£
£
-
(40,212)
(1,720,903)
-
(18,256)
(1,427,588)
15,000
(15,000)
-
-
(10,337)
(58,576)
15,000
(83,805)
(3,207,067)		 Balance at
March 2023
£
-
-
-
-
-

The restricted funds relating to building projects undertaken by the charity have been transferred to the unrestricted fund as the building works are complete and the assets are used on an unrestricted basis for any charitable purpose.

The restricted Outpatient Rehabilitation & Palliative Care Service Fund represents donations received for the provision of services by the charity.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

20 Designated funds

The income funds of the charity include the following designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes:

Movement
in funds
Incoming
resources
£
Designated fund
-
-		 Balance at
1 April 2022
£
-
-		 Transfers
Balance at
31 March 2023
£
£
1,000,000
1,000,000
1,000,000
1,000,000		 Transfers
Balance at
31 March 2023
£
£
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000

Designated funds represent amounts sent aside by the trustees in order to accumulate funds towards a future capital project.

21 Analysis of net assets between funds

Unrestricted
funds
2023
£
Fund balances at 31
March 2023 are
represented by:
Tangible assets
4,677,793
Investments
4,880,480
Current assets/(liabilities)
2,997,703
12,555,976		 Restricted
funds
2023
£
-
-
-
-		 Total Unrestricted
funds
2023
2022
£
£
4,677,793
1,485,734
4,880,480
4,612,428
2,997,703
2,391,955
12,555,976
8,490,117		 Restricted
funds
2022
£
3,275,872
-
-
3,275,872		 Total
2022
£
4,761,606
4,612,428
2,391,955
11,765,989

22 Related party transactions

Donations of £48,271 (2022: £31,194) were received during the year from the Trustees and from entities connected with the Trustees.

23 Controlling Party

The company is limited by guarantee and under the control of the Trustees.

24 Subsidiaries

Details of the charity's subsidiaries at 31 March 2023 are as follows:

Name of undertaking Registered Nature of business Class of % Held
office shares held Direct Indirect
Chai-Lifeline Services England & Wales Dormant Ordinary 100 -
Limited

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023

24 Subsidiaries

(Continued)

The aggregate capital and reserves and the result for the year of subsidiaries excluded from consolidation was as follows:

Name of undertaking
Profit/(Loss)
Capital and
Reserves
£
£
Chai-Lifeline Services
Limited
-
2
25
Cash generated from operations
Surplus for the year
Adjustments for:
Investment income recognised in statement of financial activities
Fair value gains and losses on investments
Depreciation and impairment of tangible fixed assets
Movements in working capital:
(Increase)/decrease in debtors
Increase in creditors
Cash generated from operations
26
Analysis of changes in net funds		 2023
£
789,987
(69,876)
251,538
162,175
(7,651)
53,530
1,179,703		 2022
£
665,237
(21,406)
(1,323)
164,439
131,747
39,399
978,093

The charity had no debt during the year.